Increasing concern towards skin-related disorders and rising demand for cosmetics and personal care products drive the growth of the dermal toxicity testing market.
Growing adoption of in vitro testing methods and technological advancements in the field of dermatology fuel the market growth for dermal toxicity testing.
Rising investments in research and development activities by pharmaceutical and biotechnology companies contribute to the expansion of the dermal toxicity testing market.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Type, Testing Method, Test Type, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | QIMA LTD, Charles River Laboratories, Evotec, MatTek, Erofins Scientific, SGS Group, Intertek Group, InVivo Biosystems, Eurofins Scientific, Qiagen N.V. |
Stringent regulations and guidelines imposed by regulatory authorities hamper the growth of the dermal toxicity testing market.
High cost associated with dermal toxicity testing procedures acts as a major restraint for market expansion.